
Immunoassay is a biochemical test that measures the presence or concentration of a macromolecule or a small molecule in a solution through the use of an antibody (usually) or an antigen (sometimes).
The global Quantitative Immunoassay market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Quantitative Immunoassay is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Quantitative Immunoassay is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Quantitative Immunoassay in BiologyLaboratory is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Quantitative Immunoassay include Abcam, Affymetrix, Merck Group, Bio-Rad, GE Healthcare, Thermo Fisher Scientific, Intertek Group, Luminex and Meso Scale Discovery, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Quantitative Immunoassay, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Quantitative Immunoassay.
Report Scope
The Quantitative Immunoassay market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Quantitative Immunoassay market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Quantitative Immunoassay companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abcam
Affymetrix
Merck Group
Bio-Rad
GE Healthcare
Thermo Fisher Scientific
Intertek Group
Luminex
Meso Scale Discovery
Perkin Elmer
Biotechne
Roche Applied Science
BD Biosciences
Badrilla
Segment by Type
Electrochemiluminescence Immunoassays
Bead-based Immunoassays
Segment by Application
BiologyLaboratory
Testing Center
School
Pharmaceutical Companies
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Quantitative Immunoassay companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Quantitative Immunoassay Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Electrochemiluminescence Immunoassays
1.2.3 Bead-based Immunoassays
1.3 Market by Application
1.3.1 Global Quantitative Immunoassay Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 BiologyLaboratory
1.3.3 Testing Center
1.3.4 School
1.3.5 Pharmaceutical Companies
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Quantitative Immunoassay Market Perspective (2019-2030)
2.2 Quantitative Immunoassay Growth Trends by Region
2.2.1 Global Quantitative Immunoassay Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Quantitative Immunoassay Historic Market Size by Region (2019-2024)
2.2.3 Quantitative Immunoassay Forecasted Market Size by Region (2025-2030)
2.3 Quantitative Immunoassay Market Dynamics
2.3.1 Quantitative Immunoassay Industry Trends
2.3.2 Quantitative Immunoassay Market Drivers
2.3.3 Quantitative Immunoassay Market Challenges
2.3.4 Quantitative Immunoassay Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Quantitative Immunoassay Players by Revenue
3.1.1 Global Top Quantitative Immunoassay Players by Revenue (2019-2024)
3.1.2 Global Quantitative Immunoassay Revenue Market Share by Players (2019-2024)
3.2 Global Quantitative Immunoassay Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Quantitative Immunoassay Revenue
3.4 Global Quantitative Immunoassay Market Concentration Ratio
3.4.1 Global Quantitative Immunoassay Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Quantitative Immunoassay Revenue in 2023
3.5 Quantitative Immunoassay Key Players Head office and Area Served
3.6 Key Players Quantitative Immunoassay Product Solution and Service
3.7 Date of Enter into Quantitative Immunoassay Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Quantitative Immunoassay Breakdown Data by Type
4.1 Global Quantitative Immunoassay Historic Market Size by Type (2019-2024)
4.2 Global Quantitative Immunoassay Forecasted Market Size by Type (2025-2030)
5 Quantitative Immunoassay Breakdown Data by Application
5.1 Global Quantitative Immunoassay Historic Market Size by Application (2019-2024)
5.2 Global Quantitative Immunoassay Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Quantitative Immunoassay Market Size (2019-2030)
6.2 North America Quantitative Immunoassay Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Quantitative Immunoassay Market Size by Country (2019-2024)
6.4 North America Quantitative Immunoassay Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Quantitative Immunoassay Market Size (2019-2030)
7.2 Europe Quantitative Immunoassay Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Quantitative Immunoassay Market Size by Country (2019-2024)
7.4 Europe Quantitative Immunoassay Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Quantitative Immunoassay Market Size (2019-2030)
8.2 Asia-Pacific Quantitative Immunoassay Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Quantitative Immunoassay Market Size by Region (2019-2024)
8.4 Asia-Pacific Quantitative Immunoassay Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Quantitative Immunoassay Market Size (2019-2030)
9.2 Latin America Quantitative Immunoassay Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Quantitative Immunoassay Market Size by Country (2019-2024)
9.4 Latin America Quantitative Immunoassay Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Quantitative Immunoassay Market Size (2019-2030)
10.2 Middle East & Africa Quantitative Immunoassay Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Quantitative Immunoassay Market Size by Country (2019-2024)
10.4 Middle East & Africa Quantitative Immunoassay Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abcam
11.1.1 Abcam Company Detail
11.1.2 Abcam Business Overview
11.1.3 Abcam Quantitative Immunoassay Introduction
11.1.4 Abcam Revenue in Quantitative Immunoassay Business (2019-2024)
11.1.5 Abcam Recent Development
11.2 Affymetrix
11.2.1 Affymetrix Company Detail
11.2.2 Affymetrix Business Overview
11.2.3 Affymetrix Quantitative Immunoassay Introduction
11.2.4 Affymetrix Revenue in Quantitative Immunoassay Business (2019-2024)
11.2.5 Affymetrix Recent Development
11.3 Merck Group
11.3.1 Merck Group Company Detail
11.3.2 Merck Group Business Overview
11.3.3 Merck Group Quantitative Immunoassay Introduction
11.3.4 Merck Group Revenue in Quantitative Immunoassay Business (2019-2024)
11.3.5 Merck Group Recent Development
11.4 Bio-Rad
11.4.1 Bio-Rad Company Detail
11.4.2 Bio-Rad Business Overview
11.4.3 Bio-Rad Quantitative Immunoassay Introduction
11.4.4 Bio-Rad Revenue in Quantitative Immunoassay Business (2019-2024)
11.4.5 Bio-Rad Recent Development
11.5 GE Healthcare
11.5.1 GE Healthcare Company Detail
11.5.2 GE Healthcare Business Overview
11.5.3 GE Healthcare Quantitative Immunoassay Introduction
11.5.4 GE Healthcare Revenue in Quantitative Immunoassay Business (2019-2024)
11.5.5 GE Healthcare Recent Development
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Detail
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Quantitative Immunoassay Introduction
11.6.4 Thermo Fisher Scientific Revenue in Quantitative Immunoassay Business (2019-2024)
11.6.5 Thermo Fisher Scientific Recent Development
11.7 Intertek Group
11.7.1 Intertek Group Company Detail
11.7.2 Intertek Group Business Overview
11.7.3 Intertek Group Quantitative Immunoassay Introduction
11.7.4 Intertek Group Revenue in Quantitative Immunoassay Business (2019-2024)
11.7.5 Intertek Group Recent Development
11.8 Luminex
11.8.1 Luminex Company Detail
11.8.2 Luminex Business Overview
11.8.3 Luminex Quantitative Immunoassay Introduction
11.8.4 Luminex Revenue in Quantitative Immunoassay Business (2019-2024)
11.8.5 Luminex Recent Development
11.9 Meso Scale Discovery
11.9.1 Meso Scale Discovery Company Detail
11.9.2 Meso Scale Discovery Business Overview
11.9.3 Meso Scale Discovery Quantitative Immunoassay Introduction
11.9.4 Meso Scale Discovery Revenue in Quantitative Immunoassay Business (2019-2024)
11.9.5 Meso Scale Discovery Recent Development
11.10 Perkin Elmer
11.10.1 Perkin Elmer Company Detail
11.10.2 Perkin Elmer Business Overview
11.10.3 Perkin Elmer Quantitative Immunoassay Introduction
11.10.4 Perkin Elmer Revenue in Quantitative Immunoassay Business (2019-2024)
11.10.5 Perkin Elmer Recent Development
11.11 Biotechne
11.11.1 Biotechne Company Detail
11.11.2 Biotechne Business Overview
11.11.3 Biotechne Quantitative Immunoassay Introduction
11.11.4 Biotechne Revenue in Quantitative Immunoassay Business (2019-2024)
11.11.5 Biotechne Recent Development
11.12 Roche Applied Science
11.12.1 Roche Applied Science Company Detail
11.12.2 Roche Applied Science Business Overview
11.12.3 Roche Applied Science Quantitative Immunoassay Introduction
11.12.4 Roche Applied Science Revenue in Quantitative Immunoassay Business (2019-2024)
11.12.5 Roche Applied Science Recent Development
11.13 BD Biosciences
11.13.1 BD Biosciences Company Detail
11.13.2 BD Biosciences Business Overview
11.13.3 BD Biosciences Quantitative Immunoassay Introduction
11.13.4 BD Biosciences Revenue in Quantitative Immunoassay Business (2019-2024)
11.13.5 BD Biosciences Recent Development
11.14 Badrilla
11.14.1 Badrilla Company Detail
11.14.2 Badrilla Business Overview
11.14.3 Badrilla Quantitative Immunoassay Introduction
11.14.4 Badrilla Revenue in Quantitative Immunoassay Business (2019-2024)
11.14.5 Badrilla Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Abcam
Affymetrix
Merck Group
Bio-Rad
GE Healthcare
Thermo Fisher Scientific
Intertek Group
Luminex
Meso Scale Discovery
Perkin Elmer
Biotechne
Roche Applied Science
BD Biosciences
Badrilla
Ìý
Ìý
*If Applicable.
